Douglas Richman

Update of the Drug Resistance Mutations in HIV-1: 2005.

Amalio Telenti, Victoria A Johnson, Francoise Brun-Vezinet, 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Comparison of methods to detect HIV dual infection.

Susan Little, Douglas Richman, D. Richman, 2010, AIDS research and human retroviruses.

Diagnosis of Primary HIV-1 Infection

Susan Little, Pauline Ho, Douglas Richman, 2001, Annals of Internal Medicine.

International AIDS Society global scientific strategy: towards an HIV cure 2016

Richard Jefferys, David Margolis, Jintanat Ananworanich, 2016, Nature Medicine.

Viral Dynamics of HIV: Implications for Drug Development and Therapeutic Strategies

Douglas Richman, D. Richman, Diane Havlir, 1996, Annals of Internal Medicine.

Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C

Lynn Morris, Michael S. Seaman, John R. Mascola, 2008, Journal of Virology.

Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples.

Yan Guo, Ben Murrell, Pham Phung, 2016, Virus evolution.

A new perspective on V3 phenotype prediction.

Jacques Corbeil, Douglas Richman, J. Corbeil, 2003, AIDS research and human retroviruses.

Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California.

Sergei L. Kosakovsky Pond, Susan Little, Sergei L Kosakovsky Pond, 2012, The Journal of infectious diseases.

Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity.

Susan Little, Douglas Richman, D. Richman, 2009, Virology.